Itron and Lightwell Partner to Revolutionize Smart Street Lighting and Drive Sustainable Urban Development
On January 31, 2024, Itron and Lightwell announced their partnership to provide an innovative smart street lighting solution to Fluvius,...
Wedbush Analyst Raises Price Target for Axos Financial
On January 31, 2024, Wedbush analyst David Chiaverini expressed a Neutral rating on Axos Financial (NYSE:AX) while increasing the price...
Lack of Information on Collaboration between OORT and Seagate Lyve
As of January 31, 2024, there is no concrete information available regarding any collaboration between OORT and Seagate Lyve, nor...
Wedbush Analyst Reiterates Positive Outlook for LendingClub
On January 31, 2024, Wedbush analyst David Chiaverini expressed his positive outlook for LendingClub (NYSE:LC) by reiterating an Outperform rating...
BankFinancial Reports LowerThanExpected Earnings for Q4 2023
On January 31, 2024, BankFinancial (NASDAQ:BFIN) revealed its financial results for the fourth quarter of 2023, showcasing earnings of $0.17...
Orgenesis Inc Acquires Full Ownership of Octomera LLC A Strategic Move towards Clinical Success in ImmunoOncology
On January 31, 2024, an exciting development unfolded as Orgenesis Inc. sealed a significant deal with MM OS Holdings L.P....
Orgenesis Inc Acquires Full Ownership of Octomera Solidifying Its Position in the Cell Processing Services Industry
On January 31, 2024, Orgenesis Inc (NASDAQ:ORGS) made a groundbreaking move by acquiring full ownership of Octomera, its subsidiary specializing...
Novo Nordisk Exceeds Expectations with Strong Q4 Financial Results and Promising Outlook for 2024
On January 31, 2024, Novo Nordisk, a renowned pharmaceutical company, unveiled its impressive Q4 financial results, surpassing market expectations and...
Analyst Holds Neutral Stance on PulteGroups Stock Performance
On January 31, 2024, Jay McCanless, an analyst at Wedbush, reaffirmed a Neutral rating on PulteGroup (NYSE: PHM) and upheld...
23andMe Receives FDA Approval for Groundbreaking Cancer Drug Targeting ULBP6
In a groundbreaking move, 23andMe Holding Co. (NASDAQ:ME) has received the green light from the FDA for its groundbreaking investigational...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Strategic Shift: Kazatomprom Curtails Production and Denies Listing Rumors
